Charles River Laboratories | CRL - Cost Of Sales

Stock Price
163.84
Daily Change
-2.95 -1.77%
Monthly
2.58%
Yearly
38.12%
Q2 Forecast
166.17

Charles River Laboratories reported $722.27M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Agilent USD 852M 19M Dec/2025
Align Technology USD 303.5M 60.47M Mar/2026
Bio-Rad Laboratories USD 309.6M 3.3M Sep/2025
Bruker USD 528M 46.9M Dec/2025
Cardinal Health USD 63.36B 1.57B Dec/2025
Charles River Laboratories USD 722.27M 28.81M Dec/2025
Cigna USD 63.37B 1.93B Sep/2025
Concord Medical Services Hldg CNY 204.9M 117.04M Jun/2025
CVS Health USD 92.13B 3.06B Dec/2025
Danaher USD 2.36B 512M Mar/2026
Dentsply International USD 518M 55M Dec/2025
Elevance Health USD 38.07B 75M Dec/2025
Galapagos EUR 455K 84.28M Dec/2025
Humana USD 26.54B 1.15B Mar/2025
Illumina USD 400M 49M Dec/2025
Incyte USD 121.18M 22.18M Dec/2025
Intrexon USD 1.01M 344K Jun/2024
IQVIA Holdings USD 3.24B 518M Dec/2025
Laboratory Of America USD 2.6B 56.8M Dec/2025
Lonza CHF 2.28B 189M Jun/2025
McKesson USD 102.47B 2.86B Dec/2025
Merck EUR 2.29B 183M Dec/2025
Mettler Toledo International USD 473.97M 33.71M Dec/2025
Novartis USD 3.54B 3M Dec/2025
Pfizer USD 6.29B 2.12B Dec/2025
Quest Diagnostics USD 1.99B 57M Mar/2026
Revvity USD 350.4M 26.05M Dec/2025
Thermo Fisher Scientific USD 6.96B 620M Mar/2026
United Therapeutics USD 474.7M 373.8M Dec/2025
UnitedHealth USD 94.72B 2.2B Dec/2025
Veradigm USD 124.74M 56.25M Dec/2022
Waters USD 374.94M 47.13M Dec/2025
West Pharmaceutical Services USD 548.5M 47.4M Mar/2026